Mesenchymal stromal cell secretome reduces lung injury and thrombo-inflammation induced by SARS-CoV-2 spike protein

Abstract Severe COVID-19 is characterized by thrombo-inflammatory processes within the lung microvasculature. In pursuit of effective treatments, clinical studies explored mesenchymal stromal cells (MSCs) as a promising approach due to their anti-inflammatory, immunomodulatory, and regenerative prop...

وصف كامل

التفاصيل البيبلوغرافية

المؤلفون الرئيسيون:	Anna Pezzotta, Alessandra Bovio, Barbara Imberti, Monica Locatelli, Daniela Corna, Domenico Cerullo, Sara Gastoldi, Ariela Benigni, Giuseppe Remuzzi, Marina Morigi, Luca Perico
التنسيق:	Artigo
اللغة:	Inglês
منشور في:	BMC 2025-07-01
سلاسل:	Stem Cell Research & Therapy
الموضوعات:	COVID-19 Spike protein 1 Complement Endothelial dysfunction Glycocalyx Thrombo-inflammation
الوصول للمادة أونلاين:	https://doi.org/10.1186/s13287-025-04472-6
الوسوم:	إضافة وسم لا توجد وسوم, كن أول من يضع وسما على هذه التسجيلة!